Variant ID | 29836 |
---|---|
Entrez Gene ID | 120 |
Gene | ADD3 (GeneCards) |
Location | hg19 10:111872568-111872568
hg38 10:110112810-110112810 |
Disease | Autism Spectrum Disorders (view all the variants in this disease) |
Method | NextSeq500 |
Mutation(HGVS format) | NC_000010.10:g.111872568 G>A (Genome Assembly: hg19) |
Exon or Intron | Exon |
---|---|
Position in protein | NA |
Amino acid changes in protein | NA > NA |
Position in cDNA | NA |
Changes in cDNA | NA > NA |
mRNA accession | NA |
mRNA length | NA |
Reference length | 135534747 |
MAF in gnomAD genome (version 2.0.1) | 0 |
---|---|
EIGEN score | 0.7529 |
CADD Raw score (version 1.3) | 6.651251 (Deleterious) |
FATHMM raw prediction score | 0.99585 (Tolerated) |
SIFT score | 0.005 (Deleterious) |
LRT score | 0 (Deleterious) |
MutationTaster score | 1 (Deleterious) |
MutatioinAssessor score | 2.195 (Deleterious) |
PROVEAN score | -2.55 (Deleterious) |
MetaSVM score | -1.224 (Tolerated) |
MetaLR score | 0.05 (Tolerated) |
MCAP score | 0.003 (Tolerated) |
FitCons score | 0.732 (Highly Significant p < 0.003 ) |
Genomic Evolutionary Rate Profiling (GERP) score | 5.73 |
PhyloP score based on multiple alignment of 100 vertebrates | 9.992 |
PhastCons score based on multiple alignment of 100 vertebrates | 1 |
SiPhy log transformed odds ratio on multiple alignment of 29 mammals | 20.26 |
Deleterious probability by iFish2 | 0.9657 (Deleterious) |
Deleterious probability by DeFine | 0.9602 (Deleterious) |
Entrez Gene ID | 120 (NCBI Gene) |
---|---|
Official Gene Symbol | ADD3 (GeneCards) |
Number of variants in ADD3 in this database | 2 (view all the variants) |
Full name | adducin 3 |
Band | 10q25.1-q25.2 |
Other IDs | Vega: OTTHUMG00000019032 OMIM: 601568 HGNC: HGNC:245 Ensembl: ENSG00000148700 |
Other names | ADDL, CPSQ3 |
Summary | Adducins are heteromeric proteins composed of different subunits referred to as adducin alpha, beta and gamma. The three subunits are encoded by distinct genes and belong to a family of membrane skeletal proteins involved in the assembly of spectrin-actin network in erythrocytes and at sites of cell-cell contact in epithelial tissues. While adducins alpha and gamma are ubiquitously expressed, the expression of adducin beta is restricted to brain and hematopoietic tissues. Adducin, originally purified from human erythrocytes, was found to be a heterodimer of adducins alpha and beta. Polymorphisms resulting in amino acid substitutions in these two subunits have been associated with the regulation of blood pressure in an animal model of hypertension. Heterodimers consisting of alpha and gamma subunits have also been described. Structurally, each subunit is comprised of two distinct domains. The amino-terminal region is protease resistant and globular in shape, while the carboxy-terminal region is protease sensitive. The latter contains multiple phosphorylation sites for protein kinase C, the binding site for calmodulin, and is required for association with spectrin and actin. Alternatively spliced adducin gamma transcripts encoding different isoforms have been described. The functions of the different isoforms are not known. [provided by RefSeq, Jul 2008] |
Individual ID | 28867142.10 (view all the variants in this individual) |
---|---|
Pubmed ID | 28867142 |
Whose mosaic mutation | Female Patient |
Origin of mosaic mutation in patients | de novo |
Phenotype | 3 |
Disease | Autism Spectrum Disorders (view all the variants in this disease) |
OMIM ID | 209850 |
Pubmed ID | 28867142 |
---|---|
Title | Exonic Mosaic Mutations Contribute Risk for Autism Spectrum Disorder |
Journal | American Journal of Human Genetics |
Publication date | 2017.08 |
Disease | Autism Spectrum Disorders |
Incidence | 0.01 |
Number of cases | cases of unknown sex: 247; |